Ramsay Health share price bleeds as profits plunge

COVID-19 continues to be an expensive disruptor for the hospital giant in Q3…

| More on:
A health professional sits contemplating in the corridor of a hospital.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • The Ramsay Health Care share price is trading 0.6% lower to $81.04 
  • Profits plunged during the quarter due to a number of non-recurring costs and COVID-19 disruptions 
  • The hospital operator poured $145 million into developments during the quarter 

The Ramsay Health Care Limited (ASX: RHC) share price is back in focus today after releasing its third-quarter trading update.

In early morning trade, shares in the private hospital operator are down 0.6% to $81.04.

Ramsay Health share price fails to impress

What else happened during the quarter?

The world might be returning to some form of normality, but COVID-19 still hit Ramsay Health hard in the most recent quarter. Ultimately, this is likely weighing on the Ramsay Health share price today.

According to the trading update, quantifiable impacts due to disruptions from the pandemic in Australia eclipsed $196 million for the nine months ending 31 March 2022. The healthcare giant noted that this has been a consequence of COVID-related absenteeism, surgical restrictions, and higher operating costs.

Furthermore, a similar situation played out across the company's UK operations. Although, admissions were said to be improving during the quarter. Meanwhile, Ramsay Santé experienced an increase in profits primarily from the Nordics region.

The difficult environment didn't stop Ramsay Health from continuing to invest in its expansion. During the nine months to the end of March invested around $145 million in further developments. This included more than 240 beds and nine theatres being added.

What did management say?

Cognisant of the continued COVID-19 impacts, Ramsay Health managing director and CEO Craig McNally said:

While the 3QFY22 has seen significant levels of disruption in the business due to high rates of COVID in the community, we are starting to see activity levels rise as surgical restrictions lift and our regions move into an endemic COVID setting.

Additionally, with respect to addressing the challenges being faced, McNally said:

We remain focused on our short- and long-term plans to address staff shortages and covid related fatigue among our frontline teams and to ensure that we remain an attractive place to work and an employer of choice. I would like to thank our people for continuing to live our purpose of 'People Caring for People' which has underpinned the resilience and success of the Ramsay business over many years."

What's next?

Currently, the Ramsay Health share price is a hot topic as the ASX-listed company evaluates a $20 billion takeover bid.

The last time we heard about the offer lobbed its way by the KKR consortium, the pair were conducting due diligence. The timing around the next steps is unclear as it is not yet publicly disclosed. However, it will be interesting to see if the consortium is rattled by the latest quarterly figures.

Ramsay Health share price snapshot

The Ramsay Health share price had been struggling prior to its recent takeover offer. Specifically, the company's share price was down roughly 10% on a year-to-date (YTD) basis.

However, shares rocketed higher following the offer, putting an investment in the hospital operator back in the green for the year. Now, the YTD performance stands at a 13.5% gain — outpacing the S&P/ASX 200 Index (ASX: XJO) by nearly 16%.

Motley Fool contributor Mitchell Lawler has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Ramsay Health Care Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Earnings Results

A man in a suit smiles at the yellow piggy bank he holds in his hand.
Earnings Results

Westpac shares on watch amid $6.99b profit and new buyback

Has the big four bank delivered the goods for investors this year? Let's find out.

Read more »

Woman inspecting packages.
Earnings Results

This top 50 ASX stock is diving 5% despite a strong outlook

Investors were looking for more.

Read more »

Two male ASX 200 analysts stand in an office looking at various computer screens showing share prices
Earnings Results

Macquarie share price sinks despite $1.6b half year profit and new buyback

How did this investment bank perform during the first half? Let's find out.

Read more »

A woman holds her hand out under a graphic hologram image of a human brain with brightly lit segments and section points.
Earnings Results

Why the BrainChip share price is in the spotlight this week

Today's reaction is in stark contrast to the day of the release.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

2 All Ords ASX healthcare shares making BIG moves on quarterly updates

These two ASX healthcare companies are seeing heavy trading on Thursday.

Read more »

A businesswoman ponders why her boat is sinking in the ocean.
Resources Shares

Lake Resources share price sinks on quarterly cash flow news

Let's take a look at the highlights of the company's Q3 update.

Read more »

Lithium ion batteries
Earnings Results

Needs a recharge: Novonix share price sees red after Q3 earnings

Investors were likely expecting a tad more.

Read more »

chip and tech stocks represented by two computer chips side by side
AI Stocks

Up 237% in 2024, why is the Appen share price racing higher again today?

Investors are bidding up Appen shares again today. But why?

Read more »